Header background Image

MSU’s Cisplatin Cancer Drug Wins National Golden Goose Award

In 1965, a group of Michigan State University researchers accidentally discovered a new cancer-fighting drug: cisplatin. Since then, cisplatin has become the industry standard for cancer-fighting chemotherapy treatments. MSU will receive a 2025 Golden Goose Award for the scientific success and global impact of cisplatin.
Visit the new website
$932M
2024 Research Expenditures
#1
Nationally in Department of Energy Expenditures
3,300+
Faculty Inventions
100+
Research Institutes and Centers
A graphic of a lab with a green gradient and the MSU Research Foundation logo in the foreground

The MSU Research Foundation is a valued partner, providing seed funding for new research, sponsorship of an endowed professorship program, investments in equipment, and support and venture funding for startup companies at MSU, as well as across the state in partnership with the Michigan Economic Development Corporation. 

A woman looking into a microscope
Checklist tool designed to support new researchers when setting up their first research project.
Resources for Researchers
Register by December 12, 2025.
A person using a laptop and writing with a pencil on a notebook
The Research Development and Proposal Services team provides tailored services to help MSU researchers compete for funding.
Research News
Joan Rose team conducting water research.

Research for You

With support from the federal government, Spartan researchers have delivered lifesaving breakthroughs for generations and continue to tackle our most urgent challenges. From lifesaving cancer drugs that treat millions to advancements in agriculture that help deliver healthy food to the kitchen table, Spartan research makes life better.
A dark empty lab with several lab coats hanging

The Uncertain Future of U.S. Cancer Research

Cancer research in the U.S. is backed by a complex system of interdependent funding. Partners rely heavily on each other and, when one struggles, the entire system suffers. Here, Jeffrey MacKeigan explains how cancer research funding works and what happens if there are cuts to those budgets.

Helpful Feedback

If you are unable to find or access information, please fill out our website feedback form.